Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lamont J. Barlow
Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy
Urology
Urology
Related publications
Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer
Bladder Cancer
Oncology
Urology
Study Protocol of a Phase II Clinical Trial of Oral Metformin for the Intravesical Treatment of Non-Muscle Invasive Bladder Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)
Molecular and Clinical Oncology
Cancer Research
Oncology
Humoral Immune Factor Changes in Group of Patients With Non-Muscle Invasive Bladder Cancer Treated With Intravesical Therapy.
Journal of the faculty of medicine baghdad
The Role of Molecular Genetic Alterations in Sensitivity of the Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients With Nonmuscle Invasive Bladder Cancer and Recurrence After 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
Journal of Urology
Urology
RRM1 Predicts Clinical Outcome of High-And Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Patients Treated With Intravesical Gemcitabine Monotherapy
BMC Urology
Medicine
Reproductive Medicine
Urology
The Effectiveness of Single Shot Intravesical Chemotherapy With Mitomycin-C in Preventing Recurrence of Non-Muscle Invasive Bladder Cancer
Journal of Gandhara Medical and Dental Science
Mp65-17 Intravesical Thalidomide Boosts Bacillus Calmete-Guérin (Bcg) in Non-Muscle Invasive Bladder Cancer Treatment
Journal of Urology
Urology
